http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105412120-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0d44338a9983e0302c286cb9d319ff9 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate | 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685253980351b754f8ecf6867157fabf |
publicationDate | 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105412120-A |
titleOfInvention | Application of Epishionol in preparing drugs for treating lung cancer |
abstract | The invention discloses the application of Epishionol in preparing drugs for treating lung cancer and belongs to the technical field of novel application of drugs. The compound has high anti-lung-cancer activity and can be used for preparing drugs for treating lung cancer. Epishionol can remarkably restrain in-vitro cultured non-small cell lung cancer cells A549, large cell lung cancer cells NCI-H460, lung squamous carcinoma cells HTB-8 and human lung epidermoid carcinoma cells QG-5, and has a small restraining effect on human normal hepatic cells LO2 and peripheral blood lymphocytes, and remarkable selectivity is realized. The application of Epishionol in preparing drugs for treating lung cancer is disclosed for the first time, a novel framework type is adopted, and the lung cancer cell inhibitory activity of Epishionol is surprisingly high. |
priorityDate | 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.